In vivo analysis of Drosophila deoxyribonucleoside kinase function in cell cycle, cell survival and anti-cancer drugs resistance

Cell Cycle

Volumn 5, Issue 7, 2006, Pages 740-749

  Legent, Kevin ^a   Mas, Magali ^a   Dutriaux, Annie ^a   Bertrandy, Solange ^a   Flagiello, Domenico ^a   Delanoue, Rénald ^a   Piskur, Jure ^b   Silber, Joël ^a  

^a INSTITUT JACQUES MONOD   (France)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Antifolate resistance; Apoptosis; dE2F1; Deoxyribonucleoside kinase; dNK; Drosophila; Growth; Proliferation

Indexed keywords

AMINOPTERIN; ANTINEOPLASTIC AGENT; CYCLIN E; DEOXYRIBONUCLEOSIDE; DEOXYRIBONUCLEOSIDE KINASE; FOLIC ACID ANTAGONIST; METHOTREXATE; NUCLEOTIDE; THYMIDINE KINASE; THYMIDINE KINASE 1; THYMIDINE KINASE 2; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BODY MASS; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DROSOPHILA; DRUG TOLERANCE; ENZYME ACTIVITY; ENZYME SUBSTRATE; GENE FUNCTION; GENE OVEREXPRESSION; GROWTH; IN VITRO STUDY; IN VIVO STUDY; MAMMAL; NONHUMAN; NUCLEOTIDE METABOLISM; PHASE TRANSITION; PHYSIOLOGY; TRANSGENIC ANIMAL;

ANIMALIA; DROSOPHILA MELANOGASTER; MAMMALIA;

EID: 33645702188     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.5.7.2613     Document Type: Article

References (44)

1. Eriksson S, Munch-Petersen B, Johansson K, Eklund H. Structure and function of cellular deoxyribonucleoside kinases. Cell Mol Life Sci 2002; 59:1327-46.
2. Arner ES, Eriksson S. Mammalian deoxyribonucleoside kinases. Pharmacol Ther 1995;67:155-86.
3. Attardi G, Schatz G. Biogenesis of mitochondria. Annu Rev Cell Biol 1988; 4:289-333.
4. Saada A, Shaag A, Mandel H, Nevo Y, Eriksson S, Elpeleg O. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet 2001; 29:342-4.
5. Zheng X, Lundberg M, Karlsson A, Johansson M. Lipid-mediated protein delivery of suicide nucleoside kinases. Cancer Res 2003; 63:6909-13.
6. Piskur J, Sandrini MP, Knecht W, Munch-Petersen B. Animal deoxyribonucleoside kinases: 'forward' and 'retrograde' evolution of their substrate specificity. FEBS Lett 2004; 560:3-6.
7. Munch-Petersen B, Piskur J, Sondergaard L. Four deoxynucleoside kinase activities from Drosophila melanogaster are contained within a single monomeric enzyme, a new multifunctional deoxynucleoside kinase. J Biol Chem 1998; 273:3926-31.
8. Johansson M, van Rompay AR, Degreve B, Balzarini J, Karlsson A. Cloning and characterization of the multisubstrate deoxyribonucleoside kinase of Drosophila melanogaster. J Biol Chem 1999; 274:23814-9.
9. Zheng X, Johansson M, Karlsson A. Retroviral transduction of cancer cell lines with the gene encoding Drosophila melanogaster multisubstrate deoxyribonucleoside kinase. J Biol Chem 2000; 275:39125-9.
10. Zheng X, Johansson M, Karlsson A. Bystander effects of cancer cell lines transduced with the multisubstrate deoxyribonucleoside kinase of Drosophila melanogaster and synergistic enhancement by hydroxyurea. Mol Pharmacol 2001; 60:262-6.
11. Knecht W, Munch-Petersen B, Piskur J. Polyclonal antibodies against the ultrafast multisubstrate deoxyribonucleoside kinase from Drosophila melanogaster. Adv Exp Med Biol 2000; 486:263-6.
12. Neufeld TP, de la Cruz AF, Johnston LA, Edgar BA. Coordination of growth and cell division in the Drosophila wing. Cell 1998; 93:1183-93.
13. Duman-Scheel M, Johnston LA, Du W. Repression of dMyc expression by Wingless promotes Rbf-induced G1 arrest in the presumptive Drosophila wing margin. Proc Natl Acad Sci USA 2004.
14. Johnston LA, Edgar BA. Wingless and Notch regulate cell-cycle arrest in the developing Drosophila wing. Nature 1998; 394:82-4.
15. Milan M, Campuzano S, Garcia-Bellido A. Cell cycling and patterned cell proliferation in the wing primordium of Drosophila. Proc Natl Acad Sci USA 1996; 93:640-5.
16. O'Brochta DA, Bryant PJ. A zone of nonproliferating cells at a lineage restriction boundary in Drosophila. Nature 1985; 313:138-41.
17. Munch-Petersen B, Knecht W, Lenz C, Sondergaard L, Piskur J. Functional expression of a multisubstrate deoxyribonucleoside kinase from Drosophila melanogaster and its C-terminal deletion mutants. J Biol Chem 2000; 275:6673-9.
18. Cox RT, Spradling AC. A Balbiani body and the fusome mediate mitochondrial inheritance during Drosophila oogenesis. Development 2003; 130:1579-90.
19. Johnson DG, Schwarz JK, Cress WD, Nevins JR. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 1993; 365:349-52.
20. Brand AH, Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 1993; 118:401-15.
21. Du W, Vidal M, Xie JE, Dyson N. RBF, a novel RB-related gene that regulates E2F activity and interacts with cyclin E in Drosophila. Genes Dev 1996; 10:1206-18.
22. Krajinovic M, Moghrabi A. Pharmacogenetics of methotrexate. Pharmacogenomics 2004; 5:819-34.
23. Koury MJ, Price JO, Hicks GG. Apoptosis in megaloblastic anemia occurs during DNA synthesis by a p53-independent, nucleoside-reversible mechanism. Blood 2000; 96:3249-55.
24. Van de Bor V, Delanoue R, Cossard R, Silber J. Truncated products of the vestigial proliferation gene induce apoptosis. Cell Death Differ 1999; 6:557-64.
25. Baker NE. Cell proliferation, survival, and death in the Drosophila eye. Semin Cell Dev Biol 2001; 12:499-507.
26. Bergmann A, Yang AY, Srivastava M. Regulators of IAP function: Coming to grips with the grim reaper. Curr Opin Cell Biol 2003; 15:717-24.
27. Affleck JG, Neumann K, Wong L, Walker VK. The effects of methotrexate on Drosophila development, female fecundity, and gene expression. Toxicol Sci 2005.
28. Reis T, Edgar BA. Negative regulation of dE2F1 by cyclin-dependent kinases controls cell cycle timing. Cell 2004; 117:253-64.
29. Silber J, Bazin C, Le Menn A. Vestigial mutants of Drosophila melanogaster live better in the presence of aminopterin: Increased level of dihydrofolate reductase in a mutant. Mol Gen Genet 1989; 218:475-80.
30. Montagne J, Stewart MJ, Stocker H, Hafen E, Kozma SC, Thomas G. Drosophila S6 kinase: A regulator of cell size. Science 1999; 285:2126-9.
31. Bohni R, Riesgo-Escovar J, Oldham S, Brogiolo W, Stocker H, Andruss BF, Beckingham K, Hafen E. Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IRS1-4. Cell 1999; 97:865-75.
32. Brogiolo W, Stocker H, Ikeya T, Rintelen F, Fernandez R, Hafen E. An evolutionarily conserved function of the Drosophila insulin receptor and insulin-like peptides in growth control. Curr Biol 2001; 11:213-21.
33. Banerjee D, Mayer-Kuckuk P, Capiaux G, Budak-Alpdogan T, Gorlick R, Bertino JR. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase. Biochim Biophys Acta 2002; 1587:164-73.
34. Zheng X, Johansson M, Karlsson A. Nucleoside analog cytotoxicity and bystander cell killing of cancer cells expressing Drosophila melanogaster deoxyribonucleoside kinase in the nucleus or cytosol. Biochem Biophys Res Commun 2001; 289:229-33.
35. Van Triest B, Pinedo HM, Giaccone G, Peters GJ. Downstream molecular determinants of response to 5-fluorouracil and antifolate thymidylate synthase inhibitors. Ann Oncol 2000;11:385-91.
36. Welsh SJ, Titley J, Brunton L, Valenti M, Monaghan P, Jackman AL, Aherne GW. Comparison of thymidylate synthase (TS) protein up-regulation after exposure to TS inhibitors in normal and tumor cell lines and tissues. Clin Cancer Res 2000; 6:2538-46.
37. Oliver FJ, Collins MK, Lopez-Rivas A. Overexpression of a heterologous thymidine kinase delays apoptosis induced by factor deprivation and inhibitors of deoxynucleotide metabolism. J Biol Chem 1997; 272:10624-30.
38. Knecht W, Petersen GE, Munch-Petersen B, Piskur J. Deoxyribonucleoside kinases belonging to the thymidine kinase 2 (TK2)-like group vary significantly in substrate specificity, kinetics and feed-back regulation. J Mol Biol 2002; 315:529-40.
39. Mikkelsen NE, Johansson K, Karlsson A, Knecht W, Andersen G, Piskur J, Munch-Petersen B, Eklund H. Structural basis for feedback inhibition of the deoxyribonucleoside salvage pathway: Studies of the Drosophila deoxyribonucleoside kinase. Biochemistry 2003; 42:5706-12.
40. Kauffman MG, Kelly TJ. Cell cycle regulation of thymidine kinase: Residues near the carboxyl terminus are essential for the specific degradation of the enzyme at mitosis. Mol Cell Biol 1991; 11:2538-46.
41. Dimova DK, Stevaux O, Frolov MV, Dyson NJ. Cell cycle-dependent and cell cycle-independent control of transcription by the Drosophila E2F/RB pathway. Genes Dev 2003; 17:2308-20.
42. Bernard F, Lalouette A, Gullaud M, Jeantet AY, Cossard R, Zider A, Ferveur JF, Silber J. Control of apterous by vestigial drives indirect flight muscle development in Drosophila. Dev Biol 2003; 260:391-403.
43. Delanoue R, Legent K, Godefroy N, Flagiello D, Dutriaux A, Vaudin P, Becker JL, Silber J. The Drosophila wing differentiation factor Vestigial-Scalloped is required for cell proliferation and cell survival at the dorso-ventral boundary of the wing imaginal disc. Cell Death Differ 2004; 11:110-22.
44. Richardson H, O'Keefe LV, Marty T, Saint R. Ectopic cyclin E expression induces premature entry into S phase and disrupts pattern formation in the Drosophila eye imaginal disc. Development 1995; 121:3371-9.